# Vir Biotechnology, Inc.

Canonical: https://abierto.us/vendors/vir-biotechnology-inc-vagnefk9n5x7

- UEI: VAGNEFK9N5X7
- CAGE: 80UV6
- Location: San Francisco, CA
- Awards in window: 1 (3 transactions), -$50,432,597 obligated, January 18, 2024 to August 5, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, -$50,432,597

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$50,432,597

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50122C00081 (definitive contract): -$50,432,597, Barda - Aspr / Daappo / Barda DCMA. Vir Biotechnology - OTA for Pre-Exposure Prophylactic Monoclonal Antibodies for the Prevention of Influenza Illness and Medical Countermeasures for Other Emerging Pathogens of Pandemic Potential. https://www.usaspending.gov/award/CONT_AWD_75A50122C00081_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/vir-biotechnology-inc-vagnefk9n5x7.